Comparing Misoprostol and Oxytocin in UnijectTM for Postpartum Hemorrhage (PPH) Prevention in Mali
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a large, community-based, cluster-randomized trial to compare routine prophylactic
use of 600 mcg oral misoprostol and 10 IU oxytocin delivered by UnijectTM intramuscularly
during the third stage of labor.